Non-hodgkin's Lymphoma [clinicaltrials_resource:5986165a97aee5017fcc318be3d9f88f]
clinicaltrials:NCT00176930clinicaltrials:NCT00571493Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) [clinicaltrials:NCT00944905]clinicaltrials:NCT01458288clinicaltrials:NCT01532635Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL [clinicaltrials:NCT01728207]Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [clinicaltrials:NCT02408042]
condition [clinicaltrials_vocabulary:condition]
Non-hodgkin's Lymphoma [clinicaltrials_resource:5986165a97aee5017fcc318be3d9f88f]
Bio2RDF identifier
5986165a97aee5017fcc318be3d9f88f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5986165a97aee5017fcc318be3d9f88f
identifier
clinicaltrials_resource:5986165a97aee5017fcc318be3d9f88f
title
Non-hodgkin's Lymphoma
@en
label
Non-hodgkin's Lymphoma [clinicaltrials_resource:5986165a97aee5017fcc318be3d9f88f]
@en